This hypothesis is strengthened by in vitro and in vivo analyses that showed different specificities and selectivities for CBP and p300 in the acetylation of histones, the inability of CBP to rescue the growth of p300-deficient carcinoma cell lines and an inverse prognostic correlation in CRC [24, 37, 38]. Here, EP300 is linked to carcinoma.